subalin

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namesubalin
Drug Alias NameIFN (alpha-2) (NPO Vector)alpha-2 interferon (NPO Vector)alpha-2 interferon (SRC VB Vector)alfa-2 interferon (SRC VB Vector)alfa-2 interferon (NPO Vector)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsVirus DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsVirus DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A